Lexicon Pharmaceuticals, Inc. SEC filings LXRX
Lexicon Pharmaceuticals, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jan 8, 2010. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Aug 6, 2026 | — |
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| FWP | Free writing prospectus | Feb 6, 2026 | — |
| 424B5 | Prospectus supplement | Feb 2, 2026 | — |
| FWP | Free writing prospectus | Jan 30, 2026 | — |
| FWP | Free writing prospectus | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Jan 29, 2026 | — |
| 424B5 | Prospectus supplement | Nov 6, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| S-3 | Shelf registration | Aug 2, 2024 | — |
| S-3/A | Filing | May 10, 2024 | — |
| S-3 | Shelf registration | Mar 25, 2024 | — |
| 424B5 | Prospectus supplement | Dec 29, 2023 | — |
| S-8 | Employee stock plan registration | Aug 4, 2023 | — |
| 424B5 | Prospectus supplement | Jun 2, 2023 | — |
| FWP | Free writing prospectus | Jun 1, 2023 | — |
| FWP | Free writing prospectus | May 31, 2023 | — |
| 424B5 | Prospectus supplement | May 31, 2023 | — |
| 424B5 | Prospectus supplement | Jul 29, 2022 | — |
| 424B5 | Prospectus supplement | Jul 27, 2022 | — |
| S-8 | Employee stock plan registration | Aug 6, 2021 | — |
| S-3 | Shelf registration | Aug 6, 2021 | — |
| 424B5 | Prospectus supplement | Dec 11, 2020 | — |
| 424B5 | Prospectus supplement | Oct 30, 2020 | — |
| S-8 | Employee stock plan registration | Jul 29, 2020 | — |
| S-8 | Employee stock plan registration | Nov 7, 2019 | — |
| S-3 | Shelf registration | Nov 7, 2019 | — |
| S-3ASR | Automatic shelf registration | Sep 15, 2017 | — |
| S-8 | Employee stock plan registration | May 11, 2017 | — |
| S-3ASR | Automatic shelf registration | Mar 20, 2017 | — |
| S-8 | Employee stock plan registration | Mar 11, 2016 | — |
| S-3/A | Filing | Dec 5, 2014 | — |
| S-3 | Shelf registration | Dec 3, 2014 | — |
| 424B2 | Prospectus | Nov 24, 2014 | — |
| FWP | Free writing prospectus | Nov 21, 2014 | — |
| 424B5 | Prospectus supplement | Nov 19, 2014 | — |
| S-3 | Shelf registration | Aug 29, 2014 | — |
| 424B2 | Prospectus | Oct 19, 2012 | — |
| FWP | Free writing prospectus | Oct 18, 2012 | — |
| S-3MEF | Form s-3mef | Oct 17, 2012 | — |
| 424B5 | Prospectus supplement | Oct 17, 2012 | — |
| S-3/A | Form s-3 amendment 2 | Aug 6, 2012 | — |
| S-8 | Employee stock plan registration | Aug 2, 2012 | — |
| S-3/A | Form s-3/a | Aug 1, 2012 | — |
| S-3 | Shelf registration | Jul 26, 2012 | — |
| 424B5 | Prospectus supplement | Nov 22, 2011 | — |
| POS AM | Post-effective amendment no 3 to form s-3 | Nov 3, 2011 | — |
| POS AM | Post effective amendment no 2 | Aug 15, 2011 | — |
| POS AM | Post-effective amendment | May 26, 2011 | — |
| S-3 | Shelf registration | Jan 28, 2011 | — |
| S-8 | Employee stock plan registration | Aug 9, 2010 | — |
| S-3 | Shelf registration | Aug 9, 2010 | — |
| 424B2 | Prospectus | Mar 17, 2010 | — |
| FWP | Free writing prospectus | Mar 16, 2010 | — |
| S-3MEF | Form s-3mef | Mar 15, 2010 | — |
| 424B5 | Prospectus supplement | Mar 8, 2010 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LXRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- The Woodlands, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1062822
- Former names
- LEXICON PHARMACEUTICALS, INC./DE (until Dec 5, 2014); LEXICON GENETICS INC/TX (until Apr 2, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.